Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances 16. July 2018, section EUDA news
5. June 2026 Help us shape EUDA Strategy 2030: public consultation opens today! Today, the European Union Drugs Agency (EUDA) launches a public consultation to help shape its forthcoming Strategy 2030. The...